Alzheimer’s Drug Discovery Foundation-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Alzheimer's Drug Discovery Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011851
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alzheimer’s Drug Discovery Foundation (ADDF), formerly Institute for the Study of Aging is a drug discovery foundation that offers funds for drug discovery and development research programs in the field of Alzheimer’s disease, related dementias and cognitive aging. The foundation offers services and support for development of drugs to prevent, treat, and cure Alzheimer’s disease. It offers grants to the recipients for the treatment of Alzheimer’s disease. The foundation offers funds on preclinical research and early-stage clinical trials for new drug targets. It partners with various universities, and other research and development organizations. ADDF is headquartered in New York, the US.

Alzheimer’s Drug Discovery Foundation – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Alzheimer’s Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
M3 Biotechnology Raises USD15.2 Million in Venture Financing 10
M3 Biotech Raises USD1.4 Million in Second Round of Venture Financing 12
Partnerships 13
Alzheimer Drug Discovery Enters into Research Agreement with CTI for Alzheimer’s Disease Drugs 13
Equity Offering 14
Oryzon Genomics Raises USD0.7 Million in Private Placement of Shares upon Exercise of Warrants 14
Alzheimer’s Drug Discovery Foundation – Key Competitors 15
Alzheimer’s Drug Discovery Foundation – Key Employees 16
Alzheimer’s Drug Discovery Foundation – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Government and Public Interest 18
Apr 20, 2017: ADDF-Funded Scientists Discover Two Repurposed Drugs With Promise for Alzheimers and FTD 18
Mar 01, 2017: Cypralis Announces Grant Award from Alzheimer’s Drug Discovery Foundation 19
Product News 20
Jun 07, 2017: The Alzheimer’s Drug Discovery Foundation and Science Exchange Launch ADDF ACCESS to Advance CNS Research 20
Other Significant Developments 21
Jun 07, 2017: ADDF and Science Exchange Launch ADDF ACCESS to Advance Research 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Key Facts 2
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Alzheimer's Drug Discovery Foundation, Deals By Therapy Area, 2011 to YTD 2017 8
Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
M3 Biotechnology Raises USD15.2 Million in Venture Financing 10
M3 Biotech Raises USD1.4 Million in Second Round of Venture Financing 12
Alzheimer Drug Discovery Enters into Research Agreement with CTI for Alzheimer's Disease Drugs 13
Oryzon Genomics Raises USD0.7 Million in Private Placement of Shares upon Exercise of Warrants 14
Alzheimer's Drug Discovery Foundation, Key Competitors 15
Alzheimer's Drug Discovery Foundation, Key Employees 16

★海外企業調査レポート[Alzheimer’s Drug Discovery Foundation-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tecan Group Ltd (TECN)-医療機器分野:企業M&A・提携分析
    Summary Tecan Group Ltd (Tecan) is a provider of automated laboratory instruments and solutions for use in basic and translational research, clinical diagnostics, and drug discovery. The company develops, manufactures, and markets automated workflow solutions for laboratories and instrumentation sup …
  • Green Dot Corporation:企業の戦略・SWOT・財務情報
    Green Dot Corporation - Strategy, SWOT and Corporate Finance Report Summary Green Dot Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Genuine Parts Company (GPC):企業の財務・戦略的SWOT分析
    Genuine Parts Company (GPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Rubicon Genomics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Rubicon Genomics Inc (Rubicon Genomics), a subsidiary of the Takara Bio Group is a provider of pre-analytical amplification technologies. The company offers various types of kits for whole genome sequencing (WGS), whole exome sequencing (WES), targeted sequencing, copy number variation (CNV) …
  • NuSirt Biopharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NuSirt Biopharma Inc (NuSirt Sciences) develops a technology platform that combines natural compounds with various pharmaceutical agents to prevent and treat chronic diseases resulting from over-nutrition and aging. Its technology platform focuses on activating sirtuin pathways through the a …
  • MRI Interventions Inc (MRIC):企業の財務・戦略的SWOT分析
    Summary MRI Interventions Inc (MRI Interventions) is a medical equipment company that develops and commercializes platforms for performing invasive surgical procedures. The company’s products include systems used for performing invasive surgeries on brain and heart. Its products are used for treatin …
  • Shimizu Corporation:企業の戦略・SWOT・財務分析
    Shimizu Corporation - Strategy, SWOT and Corporate Finance Report Summary Shimizu Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • ShotSpotter Inc (SSTI):企業の財務・戦略的SWOT分析
    ShotSpotter Inc (SSTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • CIRCOR International, Inc. (CIR)-石油・ガス分野:企業M&A・提携分析
    Summary CIRCOR International, Inc. (CIRCOR) is an industrial equipment company that designs, manufactures, and markets flow control solutions and engineered products and sub-systems. Its product offerings include integrated flow control solutions, high pressure pneumatic systems, valves, actuation, …
  • OBI Pharma Inc (4174):製薬・医療:M&Aディール及び事業提携情報
    Summary OBI Pharma Inc (OBI Pharma) is a biopharmaceutical company that develops therapies for the treatment of cancer and infectious diseases. The company’s products include adagloxad simolenin, an active immunotherapy which is intended for the treatment of metastatic breast cancer; and OBI-833, a …
  • BJ’s Restaurants, Inc.:企業の戦略・SWOT・財務情報
    BJ's Restaurants, Inc. - Strategy, SWOT and Corporate Finance Report Summary BJ's Restaurants, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Sumitomo Dainippon Pharma Co Ltd (4506):製薬・医療:M&Aディール及び事業提携情報
    Summary Sumitomo Dainippon Pharma Co Ltd (Sumitomo Dainippon), a subsidiary of Sumitomo Chemical Co., Ltd, develops manufacturers, purchases, sells, imports and exports pharmaceutical products. The company focuses on major therapeutic areas which include central nervous system (CNS), cardiovascular, …
  • CSS Industries, Inc. (CSS):企業の財務・戦略的SWOT分析
    CSS Industries, Inc. (CSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Sumitomo Seika Chemicals Co Ltd (4008):企業の財務・戦略的SWOT分析
    Sumitomo Seika Chemicals Co Ltd (4008) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Village Roadshow Ltd:企業の戦略・SWOT・財務情報
    Village Roadshow Ltd - Strategy, SWOT and Corporate Finance Report Summary Village Roadshow Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Shangri-La Hotels (Malaysia) Berhad:戦略・SWOT・企業財務分析
    Shangri-La Hotels (Malaysia) Berhad - Strategy, SWOT and Corporate Finance Report Summary Shangri-La Hotels (Malaysia) Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Medpace Holdings Inc (MEDP):製薬・医療:M&Aディール及び事業提携情報
    Summary Medpace Holdings Inc (Medpace) is a scientifically-driven full-service clinical contract research organization. It provides Phase I-IV outsourced clinical development services. The company also offers clinical pharmacology; and supporting laboratory services including central laboratory, bio …
  • Kajima Corporation:企業の戦略・SWOT・財務情報
    Kajima Corporation - Strategy, SWOT and Corporate Finance Report Summary Kajima Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Augmenix Inc-医療機器分野:企業M&A・提携分析
    Summary Augmenix Inc (Augmenix) is a medical device company that develops space-filling hydrogels for radiation oncology and cancer surgery indications. The company offers products such as hydrogel products, space OAR systems, absorbable tissue marker, and trace-IT hydrogel products. Its TraceIT hyd …
  • Avery Dennison Corporation (AVY):医療機器:M&Aディール及び事業提携情報
    Summary Avery Dennison Corporation (Avery Dennison) is a labeling and packaging materials and solutions provider. The company produces pressure-sensitive materials, tags, labels, tickets, and other converted products. It also manufactures and sells fasteners, tickets, tags, RFID inlays and tags, and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆